 WILMINGTON, Del., March 11, 2022 GLOBE NEWSWIRE -- Prelude Therapeutics Inc. Nasdaq: PRLD, a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will participate in a fireside chat at the Barclays 2022 Global Healthcare Conference in Miami, FL on Thursday, March 17, 2022 at 9:00 a.m. ET. 